Focus sur l'aducanumab

En juin dernier, l’agence américaine délivrant les autorisations de mise sur le marché des médicaments a autorisé l’Adulhelm, un produit qui pourrait peut-être ouvrir de nouvelles portes.

Episode metadata supplied by the publisher feed · Published Jul 23, 2021

Embed this episode

Attribution link and audio player

Ready to play

Focus sur l'aducanumab

0:00 14:01

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Vos questions, Nos réponses?

This episode is 14 minutes long.

When was this Vos questions, Nos réponses episode published?

This episode was published on July 23, 2021.

Can I download this Vos questions, Nos réponses episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!